The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 489-493 , February 2010

Ibuprofen for neuroprotection after cerebral ischemia

Presented at the 16th Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery, March 15, 2008, Singapore.

  • Yusuke Iwata, MD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
    • ,
  • Olivier Nicole, PhD

      Affiliations

    • UMR-CNRS 6185, Université Caen, Caen, France
    • ,
  • David Zurakowski, PhD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
    • ,
  • Toru Okamura, MD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
    • ,
  • Richard A. Jonas, MD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
    • Corresponding Author InformationAddress for reprints: Richard A. Jonas, MD, Children's National Heart Institute, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010.

Received 21 July 2008 ,Revised 23 April 2009 ,Accepted 18 May 2009.

References 

  1. Kaufmann WE, Andreasson KI, Isakson PC, Worley PF. Cyclooxygenases and the central nervous system. Prostaglandins. 1997;54:601–624
  2. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1997;272:3406–3410
  3. Kojo H, Fukagawa M, Tajima K, Suzuki A, Fujimura T, Aramori I, et al. Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta (beta). J Pharmacol Sci. 2003;93:347–355
  4. Cole DJ, Patel PM, Reynolds L, Drummond JC, Marcantonio S. Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume. J Pharmacol Exp Ther. 1993;266:1713–1717
  5. Park EM, Cho BP, Volpe BT, Cruz MO, Joh TH, Cho S. Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression. Neuroscience. 2005;132:625–631
  6. Pappius HM, Wolfe LS. Effects of indomethacin and ibuprofen on cerebral metabolism and blood flow in traumatized brain. J Cereb Blood Flow Metab. 1983;3:448–459
  7. Grice SC, Chappell ET, Prough DS, Whitley JM, Su M, Watkins WD. Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs. Stroke. 1987;18:787–791
  8. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261–1276
  9. Rose K, Goldberg MP, Choi DW. Cytotoxicity in murine cortical cell culture. In:  Tyson CA,  Fraizer JM editor. Vitro Biological Methods. San Diego, CA: Academic Press; 1993;p. 46–60
  10. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332:848–854
  11. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987;20:83–90
  12. Motulsky H. Intuitive Biostatistics. New York: Oxford University Press; 1995;255-67
  13. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 1989;491:394–397
  14. Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett. 1996;206:149–152
  15. McGuinness J, Neilan TG, Cummins R, Sharkasi A, Bouchier-Hayes D, Redmond JM. Intravenous glutamine enhances COX-2 activity giving cardioprotection. J Surg Res. 2008 Apr 28;[Epub ahead of print]
  16. Wong PS, Asmat A, Chan YH, Lee CN. A randomized, double-blind, placebo-controlled trial of a COX-2 inhibitor (Rofecoxib) in patients undergoing coronary artery bypass surgery. Interact Cardiovasc Thorac Surg. 2006;5:101–104

 Disclosures: None.

 Supported by National Institutes of Health R01HL060922.

PII: S0022-5223(09)01152-0

doi: 10.1016/j.jtcvs.2009.05.049

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 489-493 , February 2010

Article Tools

* Image Usage & Resolution